Media coverage
16
Media coverage
Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Morningstar.com Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752218073&p=1gw&v=1&x=lPKlUbdhucUaz0crj2P1Cw Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual M Media name/outlet Street Insider Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752161718&p=1gw&v=1&x=DX88FDNg5RgSLPIbMBn8PA Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet TMC Net Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752241637&p=1gw&v=1&x=OK__1rLFuOC7EsPo3nazxA Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its … Media name/outlet TMC Net Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752665918&p=1gw&v=1&x=HZrbzY8oZHmILE99RxcFkg Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet BioSpace Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752621733&p=1gw&v=1&x=8gfFY2kOzmxVBrtgrJb-OQ Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet ADVFN UK Country/Territory United Kingdom Date 16/05/22 URL ct.moreover.com/?a=47752178024&p=1gw&v=1&x=EGD2DWxIDNE5bpGnRb3Ffg Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Yahoo! Canada Country/Territory Canada Date 16/05/22 URL ct.moreover.com/?a=47752201423&p=1gw&v=1&x=oYlF14WFrQlaXsNHgArwUg Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Yahoo! Finance Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752225929&p=1gw&v=1&x=AGyyaEhm-xfYaOZarmpP8g Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet MarketScreener.com Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752160203&p=1gw&v=1&x=2Cb80YUq0_kJmgmwocNWUQ Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER(TM) Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Stockwatch Country/Territory Canada Date 16/05/22 URL ct.moreover.com/?a=47752162389&p=1gw&v=1&x=9F9H51G-AeNw76YJwMiQ2g Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Market Newsdesk Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752182074&p=1gw&v=1&x=r8dpvI3ij0JoqGWKMAO9xQ Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet ADVFN US Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752183997&p=1gw&v=1&x=7y0FEcj7SZdH70C4BBpAkw Persons Mathieu Nonnenmacher Title To Present Preclinical Data from its Vectorized anti HER2 Antibody Program and a Novel AAV5 Derived TRACER Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Market News Publishing Country/Territory United States Date 16/05/22 Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet GlobeNewswire Country/Territory United States Date 16/05/22 URL ct.moreover.com/?a=47752195587&p=1gw&v=1&x=xTtQa5-7zwhi_BOj2VSODw Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 16/05/22 Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet BizWire Express Country/Territory India Date 16/05/22 URL ct.moreover.com/?a=47752316721&p=1gw&v=1&x=pyzRPEjw5Db69dh7R1QoDA Persons Mathieu Nonnenmacher